Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Capecitabine/Cisplatin Chemotherapy and Chemoradiation Therapy for Gastric Adenocarcinoma
NCT00323830Phase 3Completed
- Sponsor
- Samsung Medical Center
- Start
- Oct 2004
- Primary completion
- Apr 2008
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capecitabine, cisplatin in gastric adenocarcinoma, sponsored by Samsung Medical Center. Started Oct 2004; status: completed.
02
Drugs
capecitabinecisplatin
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT00323830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323830.